Skip to content

Study · Non-randomized trial · 2001

4 results

[Pathogenesis and treatment of chronic purulent otitis media and its complications: immunological aspects].

Talyshinskiĭ AM, Garaev AR

Vestnik otorinolaringologii1 Jan 2001

PMID11510039 (opens in a new tab)PepBankPUB-11510039
Publisher pageAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. 4 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with chronic purulent otitis media, thymalin improved nonspecific defense.

    In plain wordsIn patients with chronic ear infection, thymalin improved nonspecific defense.

    Peptide
    Thymalin
    Outcome
    IncreaseNonspecific defense
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Thymalin immunocorrection improves nonspecific defense and immunity, attenuates inflammation and stimulates reparative processes in the trepanation wound of the ear.
    1 context sentence
    Summary · context
    Clinicoimmunological, microbiological and cytological examinations were made in 96 patients with otitis media purulenta chronica (OMPC) and otogenic intracranial complications.
  2. 02HumanNon-randomized trialEfficacy outcome

    In patients with chronic purulent otitis media, thymalin improved immunity.

    In plain wordsIn patients with chronic ear infection, thymalin improved immunity.

    Peptide
    Thymalin
    Outcome
    IncreaseImmunity
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Thymalin immunocorrection improves nonspecific defense and immunity, attenuates inflammation and stimulates reparative processes in the trepanation wound of the ear.
    1 context sentence
    Summary · context
    Clinicoimmunological, microbiological and cytological examinations were made in 96 patients with otitis media purulenta chronica (OMPC) and otogenic intracranial complications.
  3. 03HumanNon-randomized trialEfficacy outcome

    In patients with chronic purulent otitis media, thymalin attenuated inflammation.

    In plain wordsIn patients with chronic ear infection, thymalin reduced inflammation.

    Peptide
    Thymalin
    Outcome
    DecreaseInflammation
    Study

    n: not reported in source

    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Thymalin immunocorrection improves nonspecific defense and immunity, attenuates inflammation and stimulates reparative processes in the trepanation wound of the ear.
    1 context sentence
    Summary · context
    Clinicoimmunological, microbiological and cytological examinations were made in 96 patients with otitis media purulenta chronica (OMPC) and otogenic intracranial complications.
  4. 04HumanNon-randomized trialEfficacy outcome

    In patients with chronic purulent otitis media, thymalin stimulated repair in the ear trepanation wound.

    In plain wordsIn patients with chronic ear infection, thymalin stimulated repair of the surgical ear wound.

    Peptide
    Thymalin
    Outcome
    IncreaseTrepanation wound repair
    Study

    n: not reported in source

    Outcome group
    Wound healing · Skin and wound
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Thymalin immunocorrection improves nonspecific defense and immunity, attenuates inflammation and stimulates reparative processes in the trepanation wound of the ear.
    1 context sentence
    Summary · context
    Clinicoimmunological, microbiological and cytological examinations were made in 96 patients with otitis media purulenta chronica (OMPC) and otogenic intracranial complications.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.